Search

everythinglearnresearchcommunity

for

Search:↓

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

New treatments for hair growth and psoriasis may be possible, and gene differences could affect baldness and the severity of skin conditions.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Different cells affect hair follicle blood vessels, endothelial cells react differently to inflammation and oxidized fats, and prasugrel better protects heart vessels during a procedure than clopidogrel.

Some vaccines, like the hepatitis B vaccine, might be linked to the hair loss condition Alopecia Areata, but more research is needed.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Doctors use their experience to choose treatments for scarring hair loss because it's hard to diagnose and treat.

The document concludes that Loose Anagen Hair Syndrome is a benign condition where hair is thin and easily pulled out, often improving with age.

Examining scalp tissue under a microscope helps diagnose and understand hair loss diseases.

Treatments for hair loss include estrogen therapy and special shampoos.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Hair growth and development are controlled by specific signaling pathways.

The skin's internal clock affects healing, cancer risk, aging, immunity, and hair growth, and disruptions can harm skin health.

The TGM3 gene's promoter region is key for skin and hair cell function and may aid gene therapy.

The TGF-β family helps control how cells change and move, affecting skin, hair, and organ development.

Drosha and Dicer are essential for hair follicle health and preventing DNA damage in skin cells.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

LED therapy is safe and shows potential for treating skin conditions and promoting hair growth, but more research is needed.

Hair loss gene found on chromosome 3q26.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

Most patients treated with low-dose alpha-interferon for malignant melanoma experienced skin side effects, with hair loss being the most frequent.

Mutations in the LSS gene cause a rare type of hereditary hair loss.

Chitosan-decorated polymersomes improve finasteride delivery for hair loss treatment.

A boy with alopecia regrew hair using a vitamin D cream after other treatments failed.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Scientists created tiny particles that release medicine on the skin and in hair, working better at certain pH levels and being safe for skin cells.

Foxi3 expression in developing teeth and hair is controlled by the ectodysplasin pathway.

Eucalyptol and oleic acid in nanoemulsions improve minoxidil delivery to hair follicles, potentially enhancing hair loss treatment.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.